Posts filed under: News

MELBOURNE, Australia, and MONTREAL, Canada – 25 June 2018. Telix Pharmaceuticals has announced a technology transfer and manufacturing agreement with ISOLOGIC Innovative Radiopharmaceuticals. Access the full media release here....
Continue Reading →
Goetzpartners securities Limited (“Goetzpartners”), a leading pan-European investment bank and research firm, has initiated research coverage on Telix Pharmaceuticals Limited (“Telix”). The research report can be read here....
Continue Reading →
Telix Pharmaceuticals Ltd and ANMI SA will be running a joint user meeting for the Ga-PSMA kit at the 2018 Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting in...
Continue Reading →
MELBOURNE, Australia – 18 June 2018. Telix Pharmaceuticals today announced that a consortium of industry collaborators, including CSIRO, GE Health and ThermoFisher and Telix have been awarded an AUD $1.1m Science...
Continue Reading →
Telix has selected Goodwin Biotechnology, Inc. to optimize the process for cGMP manufacturing of our renal cancer imaging antibody drug conjugate (TLX‐ 250). The product will be used in Telix’s Phase...
Continue Reading →
The 29:81 (April 2018) edition edition of BioWorld has a very nice little write up on Telix by Tamra Sami. Thanks, Tamra for the ongoing interest in the company! Full article can...
Continue Reading →
MELBOURNE, Australia & NANTES, France, 16 April 2018 – Telix announced a research partnership with the French National Institute of Health and Medical Research (INSERM)  and the “Accelerator for Research in...
Continue Reading →
MELBOURNE, Australia, 10 April 2018 – Telix Pharmaceuticals is disclosing that a controlled entity of Telix has entered into a material contract with Endocyte, Inc. More details can be accessed...
Continue Reading →
MELBOURNE Australia, 28 March 2018 – Telix Pharmaceuticals is pleased to provide this update on the Company’s prostate imaging program. For full details click here.    ...
Continue Reading →
MELBOURNE & INDIANAPOLIS,  26 March 2018 – Telix Pharmaceuticals announced the submission of a Drug Master File (DMF) for a sterile kit used in the preparation of 68Ga-PSMA-11 (PSMA Kit),...
Continue Reading →